Opiant Pharmaceuticals to Participate at the Jefferies 2020 Virtual London Healthcare Conference

SANTA MONICA, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) --  (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, announced today that its Chief Executive Officer,